Biotechnology Journal, published by WILEY-V C H VERLAG GMBH, stands at the forefront of biotechnological research and innovation, recognized for its significant contributions to the fields of applied microbiology, molecular medicine, and broader biotechnology. With its ISSN 1860-6768 and E-ISSN 1860-7314, this journal has achieved impressive 2023 quartile rankings, positioning itself in Q1 for both Applied Microbiology and Biotechnology and Medicine (miscellaneous), and Q2 in Molecular Medicine, showcasing its impact and relevance within the scientific community. Based in Germany, the journal aims to disseminate high-quality research that drives advancements in biotechnological applications, fostering a platform for researchers, professionals, and students to engage with cutting-edge developments. With its ongoing commitment to excellence, the Biotechnology Journal is an essential resource for those seeking to stay informed about the latest trends and innovations in biotechnology.

The Electronic Journal of Biotechnology is a premier Open Access journal published by Pontificia Universidad Catolica de Valparaiso, Chile, dedicated to advancing the fields of applied microbiology and biotechnology. With its inception in 1998 and an unwavering commitment to sharing knowledge, the journal has garnered a respectable ranking within the Q3 quartile for both its biotechnology and applied microbiology categories as of 2023, reflecting its significance in the academic community. Researchers and professionals will find its editorial rigor complemented by a robust platform for disseminating innovative findings, fostering collaboration, and driving forward biotechnology discussions. Given its inclusive approach, having transitioned to Open Access in 2014, the journal ensures that research is accessible to a global audience, making it a valuable resource for students, academics, and industry practitioners alike. Through the publication of original research, reviews, and critical insights, the Electronic Journal of Biotechnology aims to bridge the gap between scientific discovery and practical application, ultimately contributing to advancements in health, agriculture, and environmental sustainability.

The JOURNAL OF BIOSCIENCE AND BIOENGINEERING, published by the SOC BIOSCIENCE BIOENGINEERING JAPAN, is an esteemed peer-reviewed journal dedicated to advancing knowledge in the fields of applied microbiology, biotechnology, and bioengineering. With its ISSN of 1389-1723 and E-ISSN 1347-4421, this journal has been providing a platform for innovative research since its inception in 1991, maintaining its relevance through periodic updates and a scope that encompasses various aspects of bioscience and engineering. The journal boasts a notable impact factor, reflecting its contributions to the Q2 and Q3 quartiles in relevant categories as of 2023, which positions it amongst the well-regarded publications in its field. Researchers and professionals can access its rich archive through open access options, ensuring wide dissemination of pivotal studies. With its address rooted in Osaka University, Japan, the journal serves as a vital resource for scientists and scholars committed to pushing the boundaries of biosciences and engineering.

Synthetic and Systems Biotechnology, published by KEAI PUBLISHING LTD, is a pioneering open-access journal that has made significant contributions to the fields of applied microbiology, biotechnology, biomedical engineering, genetics, and structural biology since its inception in 2016. With an ISSN of 2405-805X, this journal is committed to fostering innovative research and interdisciplinary collaboration, providing a platform for the dissemination of high-quality studies that push the boundaries of scientific knowledge. Recognized for its excellence, it holds prestigious Q1 rankings in both Applied Microbiology and Biotechnology as well as Biomedical Engineering in 2023, alongside notable Q2 rankings in Genetics and Structural Biology. Researchers, professionals, and students alike can access cutting-edge research that explores the dynamic interplay between synthetic biology and systems biology, driving advancements that could reshape health, industry, and environmental sustainability. By operating under an open-access model, Synthetic and Systems Biotechnology ensures that new findings are accessible to a global audience, thereby maximizing the impact and reach of the published work and paving the way for future discoveries.

ENZYME AND MICROBIAL TECHNOLOGY, a premier journal published by Elsevier Science Inc, serves as a pivotal platform for researchers and professionals dedicated to exploring the dynamic intersections of microbiology, biochemistry, and bioengineering. With a rich publication history dating back to 1979 and converging until 2024, this journal has established itself within the Q2 quartile rankings across multiple categories, including Applied Microbiology and Biotechnology, Biochemistry, Bioengineering, and Biotechnology, highlighting its influential role in advancing scientific discourse. It holds impressive Scopus rankings, where it is recognized in the 79th percentile for Applied Microbiology and Biotechnology and ranks favorably in related fields, making it a valuable resource for academic and industrial researchers looking to stay abreast of the latest developments. Although it does not currently offer Open Access options, ENZYME AND MICROBIAL TECHNOLOGY remains an essential read for anyone invested in the biotechnological applications of enzymes and microorganisms.

Microbial Cell Factories is a premier peer-reviewed journal dedicated to the field of applied microbiology and biotechnology, published by BMC in the United Kingdom since 2002. With an impressive impact factor, this journal has consistently ranked within the Q1 category across multiple disciplines, including Applied Microbiology, Bioengineering, and Biotechnology, showcasing its significance in the scientific community. The journal’s commitment to open access ensures that innovative research is freely available to researchers, professionals, and students worldwide, fostering collaboration and knowledge dissemination. With a strong presence in Scopus rankings, Microbial Cell Factories is recognized for its contributions to advancing the understanding and application of microbial processes in production systems, making it an essential resource for those involved in the microbiological and biotechnological fields.

PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, published by Taylor & Francis Inc, serves as a vital platform for advancing research in the fields of biochemistry, biotechnology, and related areas of medicine. With an ISSN of 1082-6068 and an E-ISSN of 1532-2297, this journal has established itself with a notable Q3 ranking in the 2023 categories of Biochemistry, Biotechnology, and Miscellaneous Medicine, reflecting its relevance and contribution to these disciplines. The journal encompasses a wide range of topics, providing crucial insights into preparative methods, innovative biotechnological applications, and their implications for various medical advancements. Although not open access, the journal's rich content is crucial for researchers and professionals aiming to stay abreast of the latest developments and methodologies in biochemistry and biotechnology. With an enduring commitment to excellence since its inception in 1996, the journal remains an essential resource for academics and practitioners dedicated to advancing scientific knowledge and practical applications.

BMC Biotechnology, a leading journal in the field of biotechnology, is published by BMC and has been a pivotal platform for open-access research since 2000. With a focus on the diverse areas of biotechnology, including biochemistry, genetics, and molecular biology, this journal holds a prestigious Q2 ranking in its category for 2023 and demonstrates a commendable percentile rank in the top 66th for its Scopus listings. Operating out of the United Kingdom and covering research from 2001 to 2024, BMC Biotechnology is committed to disseminating high-quality, rigorously peer-reviewed articles that foster advancements and innovations in the biotechnology landscape. Researchers, professionals, and students alike will benefit from the journal's rich content and dedicated commitment to enhancing scientific discourse within the realm of biotechnology.

Research Journal of Biotechnology is a premier publication dedicated to advancing the field of biotechnology through the dissemination of impactful research articles. Published by Research Journal Biotechnology in India, this journal operates under an Open Access model, facilitating unrestricted access to high-quality research for researchers, professionals, and students worldwide. With an ISSN of 2278-4535 and an E-ISSN of 2278-4535, the journal aims to serve as a comprehensive platform for innovative studies in Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology. Despite its current Q4 quartile ranking in these categories, the journal aspires to extend its influence and visibility in the academic community, aiming for greater impact in the future. The journal features research articles that span a wide array of topics in biotechnology, fostering a collaborative and knowledge-rich environment for national and international scholars. We invite you to explore, contribute to, and engage with the expanding landscape of biotechnological research through the Research Journal of Biotechnology.

BioTech is a forward-thinking academic journal published by MDPI, specializing in the dynamic fields of applied microbiology, biotechnology, biochemistry, bioengineering, and biomedical engineering. Established for promoting impactful research from 2021 to 2024, this journal aims to bridge the gap between laboratory findings and practical applications, serving as a vital resource for researchers, practitioners, and students alike. With its Open Access model, BioTech ensures that groundbreaking innovations are freely available to the global community, fostering collaboration and knowledge transfer across disciplines. In the 2023 rankings, BioTech holds a strong position in Q2 and Q3 quartiles across various categories, reflecting its commitment to high-quality research output. Being indexed in renowned databases, the journal enhances its visibility and reach, making it a preferred platform for sharing transformative ideas and discoveries in biotechnology and related domains. Set against the backdrop of Switzerland’s thriving research environment, BioTech is poised to become an essential resource in the rapidly evolving landscape of life sciences.